Clinical Trial Update: Acetyl Hexapeptide-8 for Blepharospasm [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Acetyl Hexapeptide-8 in blepharospasm (focal dystonia) shows terminated status with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Focal Dystonia

Drugs mentioned

• Acetyl Hexapeptide-8 (Acetyl Hexapeptide-8)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Focal Dystonia | Phase 2 | Status: TERMINATED | Results posted: 2016-11-10